Yte is a Wilmington, Delaware-based biopharmaceutical company with 2,524 employees, focusing on hematology/oncology and inflammation/autoimmunity therapeutic areas. Its product portfolio includes JAKAFI, MONJUVI, and PEMAZYRE, among others.
yte (INCY) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, yte's actual EPS was $1.16, beating the estimate of $1.04 per share, resulting in a 11.90% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
